nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—hematopoietic system—stomach cancer	0.0115	0.161	CbGeAlD
Ibandronate—FDPS—smooth muscle tissue—stomach cancer	0.0101	0.141	CbGeAlD
Ibandronate—FDPS—pancreas—stomach cancer	0.00938	0.131	CbGeAlD
Ibandronate—FDPS—lymphoid tissue—stomach cancer	0.00811	0.113	CbGeAlD
Ibandronate—FDPS—digestive system—stomach cancer	0.00801	0.112	CbGeAlD
Ibandronate—Zoledronate—CA2—stomach cancer	0.00769	0.672	CrCbGaD
Ibandronate—FDPS—bone marrow—stomach cancer	0.00739	0.103	CbGeAlD
Ibandronate—FDPS—endocrine gland—stomach cancer	0.00662	0.0923	CbGeAlD
Ibandronate—FDPS—liver—stomach cancer	0.00597	0.0832	CbGeAlD
Ibandronate—FDPS—lymph node—stomach cancer	0.00458	0.0638	CbGeAlD
Ibandronate—Risedronate—PTGS2—stomach cancer	0.00375	0.327	CrCbGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—SREBF2—stomach cancer	0.00369	0.115	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—SREBF2—stomach cancer	0.00295	0.0918	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—PRKAB1—stomach cancer	0.00281	0.0874	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—SREBF2—stomach cancer	0.00239	0.0743	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—PRKAA1—stomach cancer	0.00213	0.0662	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—RBP4—stomach cancer	0.00206	0.064	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—PPARG—stomach cancer	0.000816	0.0254	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000743	0.0231	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000622	0.0194	CbGpPWpGaD
Ibandronate—Infestation—Doxorubicin—stomach cancer	0.000618	0.000699	CcSEcCtD
Ibandronate—Infestation NOS—Doxorubicin—stomach cancer	0.000618	0.000699	CcSEcCtD
Ibandronate—Skin disorder—Docetaxel—stomach cancer	0.000614	0.000693	CcSEcCtD
Ibandronate—Renal failure—Doxorubicin—stomach cancer	0.000608	0.000687	CcSEcCtD
Ibandronate—Infection—Capecitabine—stomach cancer	0.000608	0.000687	CcSEcCtD
Ibandronate—Dizziness—Irinotecan—stomach cancer	0.000604	0.000683	CcSEcCtD
Ibandronate—Haemoglobin—Epirubicin—stomach cancer	0.000603	0.000681	CcSEcCtD
Ibandronate—Stomatitis—Doxorubicin—stomach cancer	0.000602	0.000681	CcSEcCtD
Ibandronate—Shock—Capecitabine—stomach cancer	0.000602	0.00068	CcSEcCtD
Ibandronate—Urinary tract infection—Doxorubicin—stomach cancer	0.000601	0.000679	CcSEcCtD
Ibandronate—Nervous system disorder—Capecitabine—stomach cancer	0.0006	0.000678	CcSEcCtD
Ibandronate—Haemorrhage—Epirubicin—stomach cancer	0.0006	0.000678	CcSEcCtD
Ibandronate—Eye disorder—Methotrexate—stomach cancer	0.000599	0.000677	CcSEcCtD
Ibandronate—Diarrhoea—Fluorouracil—stomach cancer	0.000599	0.000677	CcSEcCtD
Ibandronate—Pharyngitis—Epirubicin—stomach cancer	0.000595	0.000673	CcSEcCtD
Ibandronate—Cardiac disorder—Methotrexate—stomach cancer	0.000595	0.000672	CcSEcCtD
Ibandronate—Skin disorder—Capecitabine—stomach cancer	0.000594	0.000671	CcSEcCtD
Ibandronate—Sweating—Doxorubicin—stomach cancer	0.000593	0.00067	CcSEcCtD
Ibandronate—Urinary tract disorder—Epirubicin—stomach cancer	0.000592	0.000669	CcSEcCtD
Ibandronate—Hyperhidrosis—Capecitabine—stomach cancer	0.000591	0.000668	CcSEcCtD
Ibandronate—Oedema peripheral—Epirubicin—stomach cancer	0.000591	0.000668	CcSEcCtD
Ibandronate—Connective tissue disorder—Epirubicin—stomach cancer	0.000589	0.000666	CcSEcCtD
Ibandronate—Urethral disorder—Epirubicin—stomach cancer	0.000588	0.000664	CcSEcCtD
Ibandronate—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000585	0.000661	CcSEcCtD
Ibandronate—Angiopathy—Methotrexate—stomach cancer	0.000581	0.000657	CcSEcCtD
Ibandronate—Vomiting—Irinotecan—stomach cancer	0.000581	0.000657	CcSEcCtD
Ibandronate—Immune system disorder—Methotrexate—stomach cancer	0.000579	0.000654	CcSEcCtD
Ibandronate—Dizziness—Fluorouracil—stomach cancer	0.000579	0.000654	CcSEcCtD
Ibandronate—Mediastinal disorder—Methotrexate—stomach cancer	0.000577	0.000653	CcSEcCtD
Ibandronate—Rash—Irinotecan—stomach cancer	0.000576	0.000651	CcSEcCtD
Ibandronate—Dermatitis—Irinotecan—stomach cancer	0.000576	0.000651	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000575	0.00065	CcSEcCtD
Ibandronate—Chills—Methotrexate—stomach cancer	0.000575	0.00065	CcSEcCtD
Ibandronate—Headache—Irinotecan—stomach cancer	0.000572	0.000647	CcSEcCtD
Ibandronate—Insomnia—Docetaxel—stomach cancer	0.000571	0.000646	CcSEcCtD
Ibandronate—Paraesthesia—Docetaxel—stomach cancer	0.000567	0.000641	CcSEcCtD
Ibandronate—Alopecia—Methotrexate—stomach cancer	0.000566	0.00064	CcSEcCtD
Ibandronate—Mental disorder—Methotrexate—stomach cancer	0.000561	0.000635	CcSEcCtD
Ibandronate—Eye disorder—Epirubicin—stomach cancer	0.00056	0.000633	CcSEcCtD
Ibandronate—Erythema—Methotrexate—stomach cancer	0.000558	0.00063	CcSEcCtD
Ibandronate—Malnutrition—Methotrexate—stomach cancer	0.000558	0.00063	CcSEcCtD
Ibandronate—Haemoglobin—Doxorubicin—stomach cancer	0.000558	0.00063	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000557	0.00063	CcSEcCtD
Ibandronate—Cardiac disorder—Epirubicin—stomach cancer	0.000557	0.000629	CcSEcCtD
Ibandronate—Vomiting—Fluorouracil—stomach cancer	0.000556	0.000629	CcSEcCtD
Ibandronate—Dyspepsia—Docetaxel—stomach cancer	0.000556	0.000628	CcSEcCtD
Ibandronate—Haemorrhage—Doxorubicin—stomach cancer	0.000555	0.000627	CcSEcCtD
Ibandronate—Insomnia—Capecitabine—stomach cancer	0.000553	0.000625	CcSEcCtD
Ibandronate—Rash—Fluorouracil—stomach cancer	0.000552	0.000624	CcSEcCtD
Ibandronate—Dermatitis—Fluorouracil—stomach cancer	0.000551	0.000623	CcSEcCtD
Ibandronate—Pharyngitis—Doxorubicin—stomach cancer	0.000551	0.000622	CcSEcCtD
Ibandronate—Paraesthesia—Capecitabine—stomach cancer	0.000549	0.000621	CcSEcCtD
Ibandronate—Decreased appetite—Docetaxel—stomach cancer	0.000549	0.000621	CcSEcCtD
Ibandronate—Headache—Fluorouracil—stomach cancer	0.000548	0.00062	CcSEcCtD
Ibandronate—Urinary tract disorder—Doxorubicin—stomach cancer	0.000548	0.000619	CcSEcCtD
Ibandronate—Oedema peripheral—Doxorubicin—stomach cancer	0.000547	0.000618	CcSEcCtD
Ibandronate—Dysgeusia—Methotrexate—stomach cancer	0.000546	0.000617	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000545	0.000616	CcSEcCtD
Ibandronate—Connective tissue disorder—Doxorubicin—stomach cancer	0.000545	0.000616	CcSEcCtD
Ibandronate—Fatigue—Docetaxel—stomach cancer	0.000545	0.000616	CcSEcCtD
Ibandronate—Angiopathy—Epirubicin—stomach cancer	0.000544	0.000615	CcSEcCtD
Ibandronate—Urethral disorder—Doxorubicin—stomach cancer	0.000544	0.000615	CcSEcCtD
Ibandronate—Nausea—Irinotecan—stomach cancer	0.000543	0.000613	CcSEcCtD
Ibandronate—Immune system disorder—Epirubicin—stomach cancer	0.000542	0.000612	CcSEcCtD
Ibandronate—Mediastinal disorder—Epirubicin—stomach cancer	0.00054	0.000611	CcSEcCtD
Ibandronate—Constipation—Docetaxel—stomach cancer	0.00054	0.000611	CcSEcCtD
Ibandronate—Pain—Docetaxel—stomach cancer	0.00054	0.000611	CcSEcCtD
Ibandronate—Back pain—Methotrexate—stomach cancer	0.00054	0.00061	CcSEcCtD
Ibandronate—Dyspepsia—Capecitabine—stomach cancer	0.000538	0.000608	CcSEcCtD
Ibandronate—Chills—Epirubicin—stomach cancer	0.000538	0.000608	CcSEcCtD
Ibandronate—Decreased appetite—Capecitabine—stomach cancer	0.000532	0.000601	CcSEcCtD
Ibandronate—Alopecia—Epirubicin—stomach cancer	0.00053	0.000599	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000528	0.000597	CcSEcCtD
Ibandronate—Fatigue—Capecitabine—stomach cancer	0.000527	0.000596	CcSEcCtD
Ibandronate—Mental disorder—Epirubicin—stomach cancer	0.000525	0.000594	CcSEcCtD
Ibandronate—Pain—Capecitabine—stomach cancer	0.000523	0.000591	CcSEcCtD
Ibandronate—Constipation—Capecitabine—stomach cancer	0.000523	0.000591	CcSEcCtD
Ibandronate—Malnutrition—Epirubicin—stomach cancer	0.000522	0.00059	CcSEcCtD
Ibandronate—Erythema—Epirubicin—stomach cancer	0.000522	0.00059	CcSEcCtD
Ibandronate—Feeling abnormal—Docetaxel—stomach cancer	0.00052	0.000588	CcSEcCtD
Ibandronate—Nausea—Fluorouracil—stomach cancer	0.00052	0.000588	CcSEcCtD
Ibandronate—Eye disorder—Doxorubicin—stomach cancer	0.000519	0.000586	CcSEcCtD
Ibandronate—Ill-defined disorder—Methotrexate—stomach cancer	0.000518	0.000585	CcSEcCtD
Ibandronate—Gastrointestinal pain—Docetaxel—stomach cancer	0.000516	0.000584	CcSEcCtD
Ibandronate—Anaemia—Methotrexate—stomach cancer	0.000516	0.000583	CcSEcCtD
Ibandronate—Cardiac disorder—Doxorubicin—stomach cancer	0.000515	0.000582	CcSEcCtD
Ibandronate—Flatulence—Epirubicin—stomach cancer	0.000514	0.000581	CcSEcCtD
Ibandronate—FDPS—Metabolism—ACAD8—stomach cancer	0.000513	0.016	CbGpPWpGaD
Ibandronate—Dysgeusia—Epirubicin—stomach cancer	0.000511	0.000578	CcSEcCtD
Ibandronate—Back pain—Epirubicin—stomach cancer	0.000505	0.000571	CcSEcCtD
Ibandronate—Feeling abnormal—Capecitabine—stomach cancer	0.000504	0.00057	CcSEcCtD
Ibandronate—Angiopathy—Doxorubicin—stomach cancer	0.000503	0.000569	CcSEcCtD
Ibandronate—Malaise—Methotrexate—stomach cancer	0.000503	0.000569	CcSEcCtD
Ibandronate—Muscle spasms—Epirubicin—stomach cancer	0.000502	0.000567	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000502	0.0156	CbGpPWpGaD
Ibandronate—Immune system disorder—Doxorubicin—stomach cancer	0.000501	0.000566	CcSEcCtD
Ibandronate—Vertigo—Methotrexate—stomach cancer	0.000501	0.000566	CcSEcCtD
Ibandronate—Gastrointestinal pain—Capecitabine—stomach cancer	0.0005	0.000565	CcSEcCtD
Ibandronate—Mediastinal disorder—Doxorubicin—stomach cancer	0.0005	0.000565	CcSEcCtD
Ibandronate—Body temperature increased—Docetaxel—stomach cancer	0.000499	0.000564	CcSEcCtD
Ibandronate—Abdominal pain—Docetaxel—stomach cancer	0.000499	0.000564	CcSEcCtD
Ibandronate—Chills—Doxorubicin—stomach cancer	0.000498	0.000563	CcSEcCtD
Ibandronate—Alopecia—Doxorubicin—stomach cancer	0.00049	0.000554	CcSEcCtD
Ibandronate—Mental disorder—Doxorubicin—stomach cancer	0.000486	0.000549	CcSEcCtD
Ibandronate—Urticaria—Capecitabine—stomach cancer	0.000486	0.000549	CcSEcCtD
Ibandronate—Ill-defined disorder—Epirubicin—stomach cancer	0.000484	0.000547	CcSEcCtD
Ibandronate—Abdominal pain—Capecitabine—stomach cancer	0.000483	0.000546	CcSEcCtD
Ibandronate—Body temperature increased—Capecitabine—stomach cancer	0.000483	0.000546	CcSEcCtD
Ibandronate—Malnutrition—Doxorubicin—stomach cancer	0.000483	0.000546	CcSEcCtD
Ibandronate—Erythema—Doxorubicin—stomach cancer	0.000483	0.000546	CcSEcCtD
Ibandronate—Anaemia—Epirubicin—stomach cancer	0.000482	0.000545	CcSEcCtD
Ibandronate—Flatulence—Doxorubicin—stomach cancer	0.000476	0.000538	CcSEcCtD
Ibandronate—Myalgia—Methotrexate—stomach cancer	0.000475	0.000537	CcSEcCtD
Ibandronate—Chest pain—Methotrexate—stomach cancer	0.000475	0.000537	CcSEcCtD
Ibandronate—Arthralgia—Methotrexate—stomach cancer	0.000475	0.000537	CcSEcCtD
Ibandronate—Dysgeusia—Doxorubicin—stomach cancer	0.000473	0.000535	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000472	0.0147	CbGpPWpGaD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000472	0.000533	CcSEcCtD
Ibandronate—Malaise—Epirubicin—stomach cancer	0.000471	0.000532	CcSEcCtD
Ibandronate—Discomfort—Methotrexate—stomach cancer	0.000469	0.00053	CcSEcCtD
Ibandronate—Vertigo—Epirubicin—stomach cancer	0.000469	0.00053	CcSEcCtD
Ibandronate—Back pain—Doxorubicin—stomach cancer	0.000467	0.000528	CcSEcCtD
Ibandronate—Hypersensitivity—Docetaxel—stomach cancer	0.000465	0.000526	CcSEcCtD
Ibandronate—Muscle spasms—Doxorubicin—stomach cancer	0.000464	0.000525	CcSEcCtD
Ibandronate—Palpitations—Epirubicin—stomach cancer	0.000461	0.000521	CcSEcCtD
Ibandronate—FDPS—Metabolism—GMPR2—stomach cancer	0.000457	0.0142	CbGpPWpGaD
Ibandronate—Anaphylactic shock—Methotrexate—stomach cancer	0.000455	0.000515	CcSEcCtD
Ibandronate—Asthenia—Docetaxel—stomach cancer	0.000453	0.000512	CcSEcCtD
Ibandronate—Infection—Methotrexate—stomach cancer	0.000452	0.000511	CcSEcCtD
Ibandronate—Hypertension—Epirubicin—stomach cancer	0.000451	0.000509	CcSEcCtD
Ibandronate—Hypersensitivity—Capecitabine—stomach cancer	0.000451	0.000509	CcSEcCtD
Ibandronate—Ill-defined disorder—Doxorubicin—stomach cancer	0.000448	0.000507	CcSEcCtD
Ibandronate—Pruritus—Docetaxel—stomach cancer	0.000447	0.000505	CcSEcCtD
Ibandronate—Nervous system disorder—Methotrexate—stomach cancer	0.000446	0.000505	CcSEcCtD
Ibandronate—Anaemia—Doxorubicin—stomach cancer	0.000446	0.000505	CcSEcCtD
Ibandronate—Arthralgia—Epirubicin—stomach cancer	0.000444	0.000502	CcSEcCtD
Ibandronate—Myalgia—Epirubicin—stomach cancer	0.000444	0.000502	CcSEcCtD
Ibandronate—Chest pain—Epirubicin—stomach cancer	0.000444	0.000502	CcSEcCtD
Ibandronate—Anxiety—Epirubicin—stomach cancer	0.000443	0.000501	CcSEcCtD
Ibandronate—Skin disorder—Methotrexate—stomach cancer	0.000442	0.0005	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000442	0.0137	CbGpPWpGaD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000441	0.000499	CcSEcCtD
Ibandronate—Hyperhidrosis—Methotrexate—stomach cancer	0.00044	0.000497	CcSEcCtD
Ibandronate—Discomfort—Epirubicin—stomach cancer	0.000439	0.000496	CcSEcCtD
Ibandronate—Asthenia—Capecitabine—stomach cancer	0.000439	0.000496	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000436	0.0136	CbGpPWpGaD
Ibandronate—Malaise—Doxorubicin—stomach cancer	0.000436	0.000492	CcSEcCtD
Ibandronate—Dry mouth—Epirubicin—stomach cancer	0.000435	0.000491	CcSEcCtD
Ibandronate—Vertigo—Doxorubicin—stomach cancer	0.000434	0.000491	CcSEcCtD
Ibandronate—Pruritus—Capecitabine—stomach cancer	0.000433	0.000489	CcSEcCtD
Ibandronate—Diarrhoea—Docetaxel—stomach cancer	0.000432	0.000488	CcSEcCtD
Ibandronate—Palpitations—Doxorubicin—stomach cancer	0.000427	0.000482	CcSEcCtD
Ibandronate—Anaphylactic shock—Epirubicin—stomach cancer	0.000426	0.000482	CcSEcCtD
Ibandronate—Infection—Epirubicin—stomach cancer	0.000423	0.000478	CcSEcCtD
Ibandronate—Shock—Epirubicin—stomach cancer	0.000419	0.000474	CcSEcCtD
Ibandronate—FDPS—Metabolism—SUCLG1—stomach cancer	0.000418	0.013	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—IDH3B—stomach cancer	0.000418	0.013	CbGpPWpGaD
Ibandronate—Diarrhoea—Capecitabine—stomach cancer	0.000418	0.000473	CcSEcCtD
Ibandronate—Nervous system disorder—Epirubicin—stomach cancer	0.000418	0.000472	CcSEcCtD
Ibandronate—Dizziness—Docetaxel—stomach cancer	0.000418	0.000472	CcSEcCtD
Ibandronate—Hypertension—Doxorubicin—stomach cancer	0.000417	0.000471	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000415	0.000469	CcSEcCtD
Ibandronate—Skin disorder—Epirubicin—stomach cancer	0.000414	0.000468	CcSEcCtD
Ibandronate—Hyperhidrosis—Epirubicin—stomach cancer	0.000412	0.000466	CcSEcCtD
Ibandronate—Insomnia—Methotrexate—stomach cancer	0.000412	0.000465	CcSEcCtD
Ibandronate—Arthralgia—Doxorubicin—stomach cancer	0.000411	0.000465	CcSEcCtD
Ibandronate—Chest pain—Doxorubicin—stomach cancer	0.000411	0.000465	CcSEcCtD
Ibandronate—Myalgia—Doxorubicin—stomach cancer	0.000411	0.000465	CcSEcCtD
Ibandronate—Anxiety—Doxorubicin—stomach cancer	0.00041	0.000463	CcSEcCtD
Ibandronate—Paraesthesia—Methotrexate—stomach cancer	0.000409	0.000462	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000408	0.000462	CcSEcCtD
Ibandronate—Discomfort—Doxorubicin—stomach cancer	0.000406	0.000459	CcSEcCtD
Ibandronate—Dizziness—Capecitabine—stomach cancer	0.000404	0.000457	CcSEcCtD
Ibandronate—Dry mouth—Doxorubicin—stomach cancer	0.000402	0.000455	CcSEcCtD
Ibandronate—Vomiting—Docetaxel—stomach cancer	0.000402	0.000454	CcSEcCtD
Ibandronate—Dyspepsia—Methotrexate—stomach cancer	0.000401	0.000453	CcSEcCtD
Ibandronate—Rash—Docetaxel—stomach cancer	0.000398	0.00045	CcSEcCtD
Ibandronate—Dermatitis—Docetaxel—stomach cancer	0.000398	0.00045	CcSEcCtD
Ibandronate—Decreased appetite—Methotrexate—stomach cancer	0.000396	0.000447	CcSEcCtD
Ibandronate—Headache—Docetaxel—stomach cancer	0.000396	0.000447	CcSEcCtD
Ibandronate—FDPS—SREBP signalling—PIK3CA—stomach cancer	0.000395	0.0123	CbGpPWpGaD
Ibandronate—Anaphylactic shock—Doxorubicin—stomach cancer	0.000394	0.000446	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000393	0.000444	CcSEcCtD
Ibandronate—Fatigue—Methotrexate—stomach cancer	0.000392	0.000444	CcSEcCtD
Ibandronate—Infection—Doxorubicin—stomach cancer	0.000392	0.000443	CcSEcCtD
Ibandronate—Pain—Methotrexate—stomach cancer	0.000389	0.00044	CcSEcCtD
Ibandronate—FDPS—Metabolism—NDUFV1—stomach cancer	0.000389	0.0121	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NDUFS1—stomach cancer	0.000389	0.0121	CbGpPWpGaD
Ibandronate—Vomiting—Capecitabine—stomach cancer	0.000389	0.000439	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000388	0.000439	CcSEcCtD
Ibandronate—Shock—Doxorubicin—stomach cancer	0.000388	0.000438	CcSEcCtD
Ibandronate—Nervous system disorder—Doxorubicin—stomach cancer	0.000387	0.000437	CcSEcCtD
Ibandronate—Rash—Capecitabine—stomach cancer	0.000386	0.000436	CcSEcCtD
Ibandronate—Insomnia—Epirubicin—stomach cancer	0.000385	0.000436	CcSEcCtD
Ibandronate—Dermatitis—Capecitabine—stomach cancer	0.000385	0.000435	CcSEcCtD
Ibandronate—Headache—Capecitabine—stomach cancer	0.000383	0.000433	CcSEcCtD
Ibandronate—Skin disorder—Doxorubicin—stomach cancer	0.000383	0.000433	CcSEcCtD
Ibandronate—Paraesthesia—Epirubicin—stomach cancer	0.000383	0.000432	CcSEcCtD
Ibandronate—Hyperhidrosis—Doxorubicin—stomach cancer	0.000381	0.000431	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.00038	0.0118	CbGpPWpGaD
Ibandronate—Nausea—Docetaxel—stomach cancer	0.000375	0.000424	CcSEcCtD
Ibandronate—Feeling abnormal—Methotrexate—stomach cancer	0.000375	0.000424	CcSEcCtD
Ibandronate—Dyspepsia—Epirubicin—stomach cancer	0.000375	0.000424	CcSEcCtD
Ibandronate—Gastrointestinal pain—Methotrexate—stomach cancer	0.000372	0.000421	CcSEcCtD
Ibandronate—Decreased appetite—Epirubicin—stomach cancer	0.00037	0.000419	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000368	0.000416	CcSEcCtD
Ibandronate—Fatigue—Epirubicin—stomach cancer	0.000367	0.000415	CcSEcCtD
Ibandronate—Pain—Epirubicin—stomach cancer	0.000364	0.000412	CcSEcCtD
Ibandronate—Constipation—Epirubicin—stomach cancer	0.000364	0.000412	CcSEcCtD
Ibandronate—Nausea—Capecitabine—stomach cancer	0.000363	0.000411	CcSEcCtD
Ibandronate—Urticaria—Methotrexate—stomach cancer	0.000362	0.000409	CcSEcCtD
Ibandronate—Abdominal pain—Methotrexate—stomach cancer	0.00036	0.000407	CcSEcCtD
Ibandronate—Body temperature increased—Methotrexate—stomach cancer	0.00036	0.000407	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000359	0.000406	CcSEcCtD
Ibandronate—Insomnia—Doxorubicin—stomach cancer	0.000357	0.000403	CcSEcCtD
Ibandronate—Paraesthesia—Doxorubicin—stomach cancer	0.000354	0.0004	CcSEcCtD
Ibandronate—Feeling abnormal—Epirubicin—stomach cancer	0.000351	0.000397	CcSEcCtD
Ibandronate—Gastrointestinal pain—Epirubicin—stomach cancer	0.000348	0.000394	CcSEcCtD
Ibandronate—Dyspepsia—Doxorubicin—stomach cancer	0.000347	0.000392	CcSEcCtD
Ibandronate—FDPS—Metabolism—BLVRB—stomach cancer	0.000347	0.0108	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PGLS—stomach cancer	0.000347	0.0108	CbGpPWpGaD
Ibandronate—Decreased appetite—Doxorubicin—stomach cancer	0.000343	0.000387	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00034	0.000385	CcSEcCtD
Ibandronate—Fatigue—Doxorubicin—stomach cancer	0.00034	0.000384	CcSEcCtD
Ibandronate—Urticaria—Epirubicin—stomach cancer	0.000338	0.000383	CcSEcCtD
Ibandronate—Pain—Doxorubicin—stomach cancer	0.000337	0.000381	CcSEcCtD
Ibandronate—Constipation—Doxorubicin—stomach cancer	0.000337	0.000381	CcSEcCtD
Ibandronate—Abdominal pain—Epirubicin—stomach cancer	0.000337	0.000381	CcSEcCtD
Ibandronate—Body temperature increased—Epirubicin—stomach cancer	0.000337	0.000381	CcSEcCtD
Ibandronate—Hypersensitivity—Methotrexate—stomach cancer	0.000335	0.000379	CcSEcCtD
Ibandronate—FDPS—Metabolism—PPAP2A—stomach cancer	0.000331	0.0103	CbGpPWpGaD
Ibandronate—Asthenia—Methotrexate—stomach cancer	0.000327	0.000369	CcSEcCtD
Ibandronate—Feeling abnormal—Doxorubicin—stomach cancer	0.000325	0.000367	CcSEcCtD
Ibandronate—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000322	0.000364	CcSEcCtD
Ibandronate—Pruritus—Methotrexate—stomach cancer	0.000322	0.000364	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000318	0.0099	CbGpPWpGaD
Ibandronate—Hypersensitivity—Epirubicin—stomach cancer	0.000314	0.000355	CcSEcCtD
Ibandronate—Urticaria—Doxorubicin—stomach cancer	0.000313	0.000354	CcSEcCtD
Ibandronate—Abdominal pain—Doxorubicin—stomach cancer	0.000312	0.000352	CcSEcCtD
Ibandronate—Body temperature increased—Doxorubicin—stomach cancer	0.000312	0.000352	CcSEcCtD
Ibandronate—Diarrhoea—Methotrexate—stomach cancer	0.000311	0.000352	CcSEcCtD
Ibandronate—Asthenia—Epirubicin—stomach cancer	0.000306	0.000346	CcSEcCtD
Ibandronate—Pruritus—Epirubicin—stomach cancer	0.000301	0.000341	CcSEcCtD
Ibandronate—Dizziness—Methotrexate—stomach cancer	0.000301	0.00034	CcSEcCtD
Ibandronate—FDPS—Metabolism—NDUFA2—stomach cancer	0.000295	0.00917	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—FBP1—stomach cancer	0.000295	0.00917	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CA1—stomach cancer	0.000295	0.00917	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CKB—stomach cancer	0.000295	0.00917	CbGpPWpGaD
Ibandronate—Diarrhoea—Epirubicin—stomach cancer	0.000291	0.000329	CcSEcCtD
Ibandronate—Hypersensitivity—Doxorubicin—stomach cancer	0.00029	0.000328	CcSEcCtD
Ibandronate—Vomiting—Methotrexate—stomach cancer	0.000289	0.000327	CcSEcCtD
Ibandronate—Rash—Methotrexate—stomach cancer	0.000287	0.000324	CcSEcCtD
Ibandronate—Dermatitis—Methotrexate—stomach cancer	0.000287	0.000324	CcSEcCtD
Ibandronate—Headache—Methotrexate—stomach cancer	0.000285	0.000322	CcSEcCtD
Ibandronate—Asthenia—Doxorubicin—stomach cancer	0.000283	0.00032	CcSEcCtD
Ibandronate—Dizziness—Epirubicin—stomach cancer	0.000282	0.000318	CcSEcCtD
Ibandronate—Pruritus—Doxorubicin—stomach cancer	0.000279	0.000315	CcSEcCtD
Ibandronate—FDPS—Metabolism—PLIN2—stomach cancer	0.000277	0.00862	CbGpPWpGaD
Ibandronate—Vomiting—Epirubicin—stomach cancer	0.000271	0.000306	CcSEcCtD
Ibandronate—Nausea—Methotrexate—stomach cancer	0.00027	0.000306	CcSEcCtD
Ibandronate—Diarrhoea—Doxorubicin—stomach cancer	0.00027	0.000305	CcSEcCtD
Ibandronate—FDPS—Metabolism—CA2—stomach cancer	0.00027	0.00839	CbGpPWpGaD
Ibandronate—Rash—Epirubicin—stomach cancer	0.000269	0.000304	CcSEcCtD
Ibandronate—Dermatitis—Epirubicin—stomach cancer	0.000268	0.000303	CcSEcCtD
Ibandronate—Headache—Epirubicin—stomach cancer	0.000267	0.000302	CcSEcCtD
Ibandronate—FDPS—Metabolism—PGAM1—stomach cancer	0.000263	0.00818	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NT5E—stomach cancer	0.000263	0.00818	CbGpPWpGaD
Ibandronate—Dizziness—Doxorubicin—stomach cancer	0.000261	0.000295	CcSEcCtD
Ibandronate—Nausea—Epirubicin—stomach cancer	0.000253	0.000286	CcSEcCtD
Ibandronate—FDPS—Metabolism—ALDH7A1—stomach cancer	0.000251	0.0078	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PLCE1—stomach cancer	0.000251	0.0078	CbGpPWpGaD
Ibandronate—Vomiting—Doxorubicin—stomach cancer	0.000251	0.000283	CcSEcCtD
Ibandronate—Rash—Doxorubicin—stomach cancer	0.000249	0.000281	CcSEcCtD
Ibandronate—Dermatitis—Doxorubicin—stomach cancer	0.000248	0.000281	CcSEcCtD
Ibandronate—Headache—Doxorubicin—stomach cancer	0.000247	0.000279	CcSEcCtD
Ibandronate—FDPS—Metabolism—UMPS—stomach cancer	0.00024	0.00748	CbGpPWpGaD
Ibandronate—Nausea—Doxorubicin—stomach cancer	0.000234	0.000265	CcSEcCtD
Ibandronate—FDPS—Metabolism—PDHA1—stomach cancer	0.000223	0.00695	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ECHS1—stomach cancer	0.000223	0.00695	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—FADS1—stomach cancer	0.00021	0.00654	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—TYMP—stomach cancer	0.00021	0.00654	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SREBF2—stomach cancer	0.000197	0.00612	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—RORA—stomach cancer	0.000194	0.00605	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ALDOB—stomach cancer	0.000182	0.00567	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.000172	0.00534	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.000171	0.00533	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ALOX5—stomach cancer	0.000169	0.00527	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—DPYD—stomach cancer	0.000167	0.00518	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	0.000151	0.0047	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTT1—stomach cancer	0.000147	0.00458	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP2A6—stomach cancer	0.000146	0.00453	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AKR1C3—stomach cancer	0.000142	0.00441	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ENO1—stomach cancer	0.000138	0.00429	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.000136	0.00422	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CD44—stomach cancer	0.000122	0.00381	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	0.000119	0.0037	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPP2R1A—stomach cancer	0.000104	0.00324	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTP1—stomach cancer	0.000102	0.00318	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HMOX1—stomach cancer	0.000101	0.00313	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—TYMS—stomach cancer	9.49e-05	0.00295	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTM1—stomach cancer	9.38e-05	0.00292	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ERCC2—stomach cancer	8.82e-05	0.00274	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MTHFR—stomach cancer	8.29e-05	0.00258	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CAV1—stomach cancer	7.65e-05	0.00238	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOA1—stomach cancer	7.63e-05	0.00237	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.31e-05	0.00227	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPARG—stomach cancer	6.72e-05	0.00209	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ALB—stomach cancer	6.05e-05	0.00188	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NOS3—stomach cancer	5.78e-05	0.0018	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PTGS2—stomach cancer	5.29e-05	0.00165	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PIK3CA—stomach cancer	3.25e-05	0.00101	CbGpPWpGaD
